Skip to main content
. 2018 Jun 18;13(6):e0199211. doi: 10.1371/journal.pone.0199211

Fig 4. Imunohistochemistry for TLR1, TLR2, TLR4, TLR5, and TLR6 in GBM cases.

Fig 4

Positive immunolabelling of GBM tumor cells for TLRs are demonstrated at 600x magnification of tumor tissues, and at 800x magnification in a multinucleated GBM tumor cell. The distribution of the Immunolabeling score (ILS) for these TLRs in five GBM cases was presented as a dispersion graph, where the black dots represent the mean ILS obtained by the two independent investigators for each individual tumor case, and the horizontal bar represent the mean ILS for each receptor. TLR4 and TLR5 positive staining were detected in tumor nuclei.